136 related articles for article (PubMed ID: 2249896)
1. Eradication of a disseminated mouse lymphoma by 1,3-bis(2-chloroethyl)-1-nitrosourea is immunologically mediated and accompanied by de novo generation of anti-tumor cytotoxicity.
Sensi M; Bergomi M; Formelli F; Parmiani G
Int J Cancer; 1990 Dec; 46(6):1088-94. PubMed ID: 2249896
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of BCNU on T cell, macrophage, natural killer and lymphokine-activated killer cell activities in mice bearing a syngeneic tumor.
Nagarkatti M; Nagarkatti PS; Kaplan AM
Cancer Immunol Immunother; 1988; 27(1):38-46. PubMed ID: 3260820
[TBL] [Abstract][Full Text] [Related]
3. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
Sensi M; Orosz CG; Bach FH
J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778
[TBL] [Abstract][Full Text] [Related]
4. The role of suppressor T cells in BCNU-mediated rejection of a syngeneic tumor.
Nagarkatti M; Kaplan AM
J Immunol; 1985 Aug; 135(2):1510-7. PubMed ID: 3159794
[TBL] [Abstract][Full Text] [Related]
5. Evidence for host resistance in 1,3 bis(2-chloroethyl)-1-nitrosourea treatment induced in syngeneic LSA lymphoma.
Maruyama Y; Williams A; Feola JM; Nava C
J Cancer Res Clin Oncol; 1982; 103(2):107-18. PubMed ID: 7096433
[TBL] [Abstract][Full Text] [Related]
6. Characterization of T lymphocyte clones isolated from BCNU-cured LSA mice.
Selvan RS; Nagarkatti PS; Nagarkatti M
Int J Cell Cloning; 1991 Nov; 9(6):594-605. PubMed ID: 1770232
[TBL] [Abstract][Full Text] [Related]
7. DBA/2-like minor histocompatibility antigens on a BALB/c lymphoma. A BALB/c anti-DBA/2 serum which lyses the tumor and blocks BALB/c anti-tumor and anti-DBA/2 effectors.
Ballinari D; Grazioli L; Sensi ML; Borrello MG; Parmiani G
Int J Cancer; 1985 Nov; 36(5):617-22. PubMed ID: 3877002
[TBL] [Abstract][Full Text] [Related]
8. Elimination of EL-4 and L1210 murine tumors by 1,3-bis (2-chloroethyl)-1-nitrosourea requires an intact immune response.
Steele TA; Cox DC
Proc Soc Exp Biol Med; 1996 May; 212(1):63-8. PubMed ID: 8618953
[TBL] [Abstract][Full Text] [Related]
9. Alloreactivity and tumor antigens: generation of syngeneic antilymphoma killer lymphocytes by alloimmunization of mice with normal cells.
Sensi ML; Parenza M; Parmiani G
J Natl Cancer Inst; 1983 Feb; 70(2):291-7. PubMed ID: 6571938
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the cellular immune response to and adoptive immunotherapy of a BALB/c lymphoma that cross-reacts with normal DBA/2 cells.
Sensi M; Grazioli L; Parmiani G
Cancer Immunol Immunother; 1986; 21(3):199-204. PubMed ID: 2938737
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-7 mediates the generation and expansion of murine allosensitized and antitumor CTL.
Jicha DL; Schwarz S; Mulé JJ; Rosenberg SA
Cell Immunol; 1992 Apr; 141(1):71-83. PubMed ID: 1555257
[TBL] [Abstract][Full Text] [Related]
12. Induction and characterization of minor histocompatibility antigens. Specific primary cytotoxic T lymphocyte responses in vitro.
Ando K; Nakashima I; Nagase F; Isobe K; Kawashima K; Hasegawa Y; Yoshida T; Iwamoto T; Hasegawa T; Muro Y
J Immunol; 1988 Feb; 140(3):723-9. PubMed ID: 2448374
[TBL] [Abstract][Full Text] [Related]
13. Adoptive immunotherapy of a BALB/c lymphoma by syngeneic anti-DBA/2 immune lymphoid cells: characterization of the effector population and evidence for the role of the host's non-T cells.
Colombo MP; Parenza M; Parmiani G
Cancer Immunol Immunother; 1985; 20(3):198-204. PubMed ID: 3851699
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy of mice bearing syngeneic tumors with 1,3-bis (2-chloroethyl)-1-nitrosourea is effective only in normal, but not in irradiated or nude, mice: role of L3T4+ (CD4+) and Lyt-2+ (CD8+) T cells.
Nagarkatti M; Seth A; Nagarkatti PS
Cell Immunol; 1988 Sep; 115(2):383-92. PubMed ID: 3261638
[TBL] [Abstract][Full Text] [Related]
15. Conditioning of the secondary cytotoxic T-lymphocyte response to YC8 tumor.
Ghanta VK; Hiramoto NS; Soong SJ; Hiramoto RN
Pharmacol Biochem Behav; 1995 Mar; 50(3):399-403. PubMed ID: 7617678
[TBL] [Abstract][Full Text] [Related]
16. Role of IL-2, IL-4 and IL-6 in the growth and differentiation of tumor-specific CD4+ T helper and CD8+ T cytotoxic cells.
Selvan RS; Nagarkatti PS; Nagarkatti M
Int J Cancer; 1990 Jun; 45(6):1096-104. PubMed ID: 1972141
[TBL] [Abstract][Full Text] [Related]
17. Immunomodulation by various nitrosoureas and its effect on the survival of the murine host bearing a syngeneic tumor.
Nagarkatti M; Toney DM; Nagarkatti PS
Cancer Res; 1989 Dec; 49(23):6587-92. PubMed ID: 2573418
[TBL] [Abstract][Full Text] [Related]
18. Differential resistance to growth of a tumor expressing incompatible minor alloantigens reflects regulatory influences rather than differences in anti-minor-CTL-P frequencies.
Carayanniotis G; Halloran PF
Cell Immunol; 1985 Mar; 91(1):100-10. PubMed ID: 2857596
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-beta inhibits the in vitro generation of lymphokine-activated killer cells and cytotoxic T cells.
Mulé JJ; Schwarz SL; Roberts AB; Sporn MB; Rosenberg SA
Cancer Immunol Immunother; 1988; 26(2):95-100. PubMed ID: 2452015
[TBL] [Abstract][Full Text] [Related]
20. Passive adoptive immunotherapy of low-immunogenic BALB/c lymphoma by syngeneic alloimmune T lymphocytes.
Colombo MP; Arioli I; Parmiani G
Int J Cancer; 1984 Dec; 34(6):807-13. PubMed ID: 6334656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
